Skip to main content
Delfa

← Trials/Trial dossier/NCT00083421

CompletedPhase 2

Effects of ONO-2506PO in Patients With Alzheimer's Disease

Lead sponsor

Ono Pharma USA Inc

Asset

ONO-2506PO

Listed sites

87

Recruiting sites

-

Enrollment

647

actual

Study population

Alzheimer’s disease

Key I/E criteria

•Alzheimer's disease•MMSE 13-24

Primary endpoints

•Cognitive Function Scale•Global Function Scale

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT00083421
Org study IDONO-2506POU010

Timeline

Milestones

Study start2004-06 (month precision)
Study first posted2004-06-18estimated
Study completion2007-07actual (month precision)
Last update posted2012-06-13estimated

Assets

Drug assets

ONO-2506PO

Study populations

Who this study enrolls

Alzheimer’s disease

Eligibility

Who can enroll

Minimum age50 Years
Maximum age90 Years
SexAll
Healthy volunteersNot accepted

Inclusion criteria

•Diagnosis of probable Alzheimer's Disease using NINCDS/ADRDA criteria
•Standardized MMSE Score of 13 to 24 points (inclusive)
•Modified Hachinski score equal or less than 4

Exclusion criteria

•Serious systemic disease that may preclude survival to study completion
•Other illnesses that may include dementive features

Endpoints (4)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Coverage by outcome category

Other (unclassified)
3
Global cognition
1

Global cognition

1 endpoint
Primary/protocol endpoint

Cognitive Function Scale

descriptive

Other (unclassified)

3 endpoints
Primary/protocol endpoint/low confidence

Global Function Scale

descriptive

Secondary/protocol endpoint/low confidence

ADL Scale

descriptive

Secondary/protocol endpoint/low confidence

Psychiatric Symptom Scale

descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 21, 2026
Endpoint classificationDelfa ADRD endpoint taxonomy
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 21, 2026 snapshot.